1. Home
  2. MPAA vs ALT Comparison

MPAA vs ALT Comparison

Compare MPAA & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MPAA
  • ALT
  • Stock Information
  • Founded
  • MPAA 1968
  • ALT 1997
  • Country
  • MPAA United States
  • ALT United States
  • Employees
  • MPAA N/A
  • ALT N/A
  • Industry
  • MPAA Auto Parts:O.E.M.
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • MPAA Consumer Discretionary
  • ALT Health Care
  • Exchange
  • MPAA Nasdaq
  • ALT Nasdaq
  • Market Cap
  • MPAA 281.2M
  • ALT 327.4M
  • IPO Year
  • MPAA 1994
  • ALT N/A
  • Fundamental
  • Price
  • MPAA $16.00
  • ALT $3.57
  • Analyst Decision
  • MPAA
  • ALT Strong Buy
  • Analyst Count
  • MPAA 0
  • ALT 6
  • Target Price
  • MPAA N/A
  • ALT $17.40
  • AVG Volume (30 Days)
  • MPAA 163.1K
  • ALT 2.3M
  • Earning Date
  • MPAA 11-11-2025
  • ALT 11-11-2025
  • Dividend Yield
  • MPAA N/A
  • ALT N/A
  • EPS Growth
  • MPAA N/A
  • ALT N/A
  • EPS
  • MPAA 0.08
  • ALT N/A
  • Revenue
  • MPAA $775,831,000.00
  • ALT $20,000.00
  • Revenue This Year
  • MPAA $10.44
  • ALT N/A
  • Revenue Next Year
  • MPAA $4.88
  • ALT $761,880.20
  • P/E Ratio
  • MPAA $200.82
  • ALT N/A
  • Revenue Growth
  • MPAA 6.59
  • ALT N/A
  • 52 Week Low
  • MPAA $5.16
  • ALT $2.90
  • 52 Week High
  • MPAA $16.59
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • MPAA 66.82
  • ALT 44.06
  • Support Level
  • MPAA $15.55
  • ALT $3.54
  • Resistance Level
  • MPAA $16.30
  • ALT $3.72
  • Average True Range (ATR)
  • MPAA 0.60
  • ALT 0.16
  • MACD
  • MPAA 0.05
  • ALT 0.01
  • Stochastic Oscillator
  • MPAA 75.21
  • ALT 10.94

About MPAA Motorcar Parts of America Inc.

Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts and test solutions and diagnostic equipment. It operate in the non-discretionary automotive aftermarket for replacement hard part in North America and includes products such as light-duty rotating electrical products, wheel hub products, brake-related products, and turbochargers. In addition, it sell test solutions and diagnostic equipment. The company operates in three segments Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty. Key revenue is generated from Hard Parts, which includes (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: